Policy · 2026-05-19
Philadelphia City Council Schedules Hearing on Bill That Would Effectively Ban Natural Kratom Leaf Citywide
Source: Super Speciosa / Protect Kratom
Why it matters
Philadelphia City Council is considering legislation that, while framed as consumer protection, would in practice ban all natural kratom sales by requiring FDA pharmaceutical drug approval — a standard impossible for botanical products to meet. The outcome could set a precedent for other major cities.
The big picture
Bill 260163, introduced by Councilmember Katherine Gilmore Richardson, would regulate intoxicating substances including kratom and hemp products. The bill includes consumer protections praised by regulation advocates — age-21 requirements, 2% 7-OH caps, lab testing, and labeling mandates. However, a provision requiring FDA Section 505 pharmaceutical approval creates what critics call a de facto prohibition, since no kratom product can obtain pharmaceutical drug approval under current regulatory frameworks.
Key findings
- Philadelphia City Council's Committee on Commerce & Economic Development scheduled a hearing for May 21, 2026 at City Hall, Room 400
- Bill 260163 would require FDA pharmaceutical drug approval (Section 505) for any kratom product to be sold legally in Philadelphia
- The bill does include consumer-friendly provisions: age 21+, 2% 7-OH cap, synthetic alkaloid ban, lab testing, and labeling requirements
- Critics argue the FDA approval clause makes all other regulatory provisions meaningless, since no botanical kratom can meet pharmaceutical drug standards
- The FDA has itself differentiated between natural kratom leaf and synthetic 7-OH concentrates in its own regulatory guidance
What they say
Kratom advocates from Protect Kratom characterized the bill as 'prohibition by another name,' arguing: 'Applying a pharmaceutical drug approval requirement to a natural botanical product is not consumer protection. It is prohibition by another name.'
Bottom line
Philadelphia's proposed kratom legislation contains real consumer protections, but a buried FDA pharmaceutical approval clause would effectively ban all natural kratom sales — making it one of the most sweeping city-level kratom restrictions in the country if passed.